Spago Nanomedical AB (publ) (FRA:7UX)

Spago Nanomedical AB Revenue

Spago Nanomedical AB had revenue of 1.25M SEK in the quarter ending September 30, 2025, a decrease of -19.56%. This brings the company's revenue in the last twelve months to 5.84M, down -16.35% year-over-year. In the year 2024, Spago Nanomedical AB had annual revenue of 6.65M with 17.94% growth.

• Revenue (ttm): 5.84M SEK
• Revenue Growth: -16.35%
• P/S Ratio: 6.66
• Revenue / Employee: 449.38K SEK
• Employees: 13
• Market Cap: 3.52M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.65M	1.01M	17.94%
Dec 31, 2023	5.64M	-562.00K	-9.06%
Dec 31, 2022	6.20M	-279.00K	-4.30%
Dec 31, 2021	6.48M	-679.00K	-9.48%
Dec 31, 2020	7.16M	-11.80M	-62.23%